ストックスクリーナーアプリを入手
0.6351
2.27%
0.0141
プレマーケット:
.62
-0.0151
-2.38%
前日終値:
$0.621
開ける：
$0.62
24時間の取引高:
129.52K
Relative Volume:
0.11
時価総額：
$10.00M
収益：
-
当期純損益:
$-29.56M
株価収益率:
-0.3226
EPS:
-1.9688
ネットキャッシュフロー:
$-21.21M
1週間 パフォーマンス:
+1.94%
1か月 パフォーマンス:
-23.48%
6か月 パフォーマンス:
-79.77%
1年 パフォーマンス:
-60.31%
1日の値動き範囲:
$0.6056
$0.6425
1週間の範囲:
$0.6056
$0.6999
52週間の値動き範囲:
$0.4606
$7.20
Calcimedica Inc Stock (CALC) Company Profile
Compare CALC vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CALC
Calcimedica Inc
|
0.6351 | 9.78M | 0 | -29.56M | -21.21M | -1.9688 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Calcimedica Inc Stock (CALC) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-29 | ダウングレード | H.C. Wainwright | Buy → Neutral |
Calcimedica Inc (CALC) 最新ニュース
CALC Options Chain — NASDAQ:CALC - TradingView — Track All Markets
MACD Signal: Does CalciMedica Inc outperform in volatile marketsMarket Sentiment Report & AI Enhanced Trading Alerts - baoquankhu1.vn
Profit Review: Does CalciMedica Inc have consistent dividend growth2026 Growth vs Value & Accurate Technical Buy Alerts - baoquankhu1.vn
EPS Watch: Is CalciMedica Inc attractive for institutional investorsPortfolio Gains Summary & Real-Time Volume Analysis Alerts - baoquankhu1.vn
Jobs Data: Is CalciMedica Inc exposed to currency risks2026 PostEarnings & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
CalciMedica (NASDAQ: CALC) grants CSO 65,124 options at $0.585 - Stock Titan
CalciMedica (CALC) awards CBO 83,358 stock options at $0.585 - Stock Titan
CalciMedica (CALC) grants 65,124 stock options to President and COO - Stock Titan
Earnings Risk: Does CalciMedica Inc meet Warren Buffetts criteriaMarket Growth Review & Fast Momentum Entry Tips - baoquankhu1.vn
CalciMedica (CALC) CEO awarded 148,482 stock options at $0.585 - Stock Titan
CALC PE Ratio & Valuation, Is CALC Overvalued - Intellectia AI
CALC Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
CalciMedica (CALC) price target decreased by 24.39% to 10.54 - MSN
If You Invested $1,000 in CALCIMEDICA INC (CALC) - Stock Titan
Revenue Check: Does CalciMedica Inc meet Warren Buffetts criteria2026 Drop Watch & Detailed Earnings Play Alerts - baoquankhu1.vn
Big Picture: Does CalciMedica Inc meet Warren Buffetts criteriaShare Buyback & Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
CalciMedica receives Nasdaq delisting notices for market value and bid price - Investing.com Australia
CalciMedica Receives Nasdaq Deficiency Notices on Listing Standards - TipRanks
CalciMedica Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
CalciMedica (NASDAQ: CALC) faces Nasdaq market value and $1 bid price breaches - Stock Titan
Analysis Recap: Can CalciMedica Inc outperform in the next rally2026 News Drivers & Fast Entry High Yield Stock Tips - baoquankhu1.vn
US Market Recap: Is CalciMedica Inc stock a smart retirement pick2026 Price Momentum & Daily Price Action Insights - baoquankhu1.vn
Latest CALC NewsCalciMedica Reports Second Quarter 2023 Fin... - Stock Titan
[EFFECT] CalciMedica, Inc. SEC Filing - Stock Titan
Analysts’ Top Healthcare Picks: Dianthus Therapeutics (DNTH), CalciMedica (CALC) - The Globe and Mail
Oppenheimer Cuts CalciMedica (NASDAQ:CALC) Price Target to $10.00 - Defense World
Aug Highlights: Can CalciMedica Inc outperform in the next rally2025 Top Gainers & Consistent Profit Trading Strategies - baoquankhu1.vn
Performance Recap: Should I set a stop loss on CalciMedica Inc2025 Momentum Check & Safe Entry Point Identification - baoquankhu1.vn
CalciMedica, Inc. Common Stock share price - livemint.com
CalciMedica (CALC) Receives Updated Analyst Rating from Oppenhei - GuruFocus
Oppenheimer Adjusts CalciMedica Price Target to $10 From $20, Maintains Outperform Rating - marketscreener.com
CalciMedica price target lowered to $10 from $20 at Oppenheimer - TipRanks
CALC Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Analysts’ Opinions Are Mixed on These Healthcare Stocks: CalciMedica (CALC) and Talphera (TLPH) - The Globe and Mail
Calcimedica Inc files for mixed shelf of up to $125 millionSEC filing - marketscreener.com
Calcimedica Inc Files For Mixed Shelf Of Up To $125 MillionSEC Filing - TradingView
CalciMedica (NASDAQ: CALC) files shelf to offer up to $125M in securities - Stock Titan
CalciMedica, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
CalciMedica (NASDAQ: CALC) outlines Auxora pipeline, halted AKI trial and going concern risk - Stock Titan
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
CalciMedica (Nasdaq: CALC) widens 2025 loss while advancing Auxora and PAH candidate - Stock Titan
CalciMedica Reports 2025 Financial Results and Provides Clinical Updates - PR Newswire
CalciMedica, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
Retail Trends: Whats next for CalciMedica Inc stock2025 Sector Review & Technical Entry and Exit Tips - baoquankhu1.vn
CALC Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
CALC SEC FilingsCALCIMEDICA INC 10-K, 10-Q, 8-K Forms - Stock Titan
Jobs Data: Is Vistagen Therapeutics Inc. stock a top pick in earnings seasonGold Moves & Reliable Intraday Trade Alerts - baoquankhu1.vn
Does CalciMedica Inc. meet Warren Buffett’s criteria2025 Stock Rankings & Weekly High Conviction Ideas - mfd.ru
CALC Should I Buy - Intellectia AI
Should I set a stop loss on CalciMedica Inc.July 2025 Momentum & Weekly Watchlist for Consistent Profits - mfd.ru
Aug Highlights: What’s the fair value of DUK.PRA stockQuarterly Trade Review & Free Real-Time Market Sentiment Alerts - baoquankhu1.vn
Calcimedica Inc (CALC) 財務データ
収益
当期純利益
現金流量
EPS
2.69%
0.25%
大文字化:
|
ボリューム (24 時間):